What is MIRA Pharmaceuticals, Inc. Common Stock (MIRA) stock price today?

MIRA Pharmaceuticals, Inc. Common Stock (MIRA) currently trades at $1.05 per share. The stock has a market capitalization of $42.86M and a P/E ratio of —x.

Is MIRA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, MIRA Pharmaceuticals, Inc. Common Stock has a Smart Value Score of 18/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is —.

Is MIRA Pharmaceuticals, Inc. Common Stock financially healthy?

MIRA Pharmaceuticals, Inc. Common Stock's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of — places it in the —.

MIRA

MIRA Pharmaceuticals, Inc. Common Stock

NASDAQ: MIRA · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

$1.05

+2.94% today

Updated 2026-04-30

Market cap

$42.86M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.35

Dividend yield

—

52W range

$1 – $2

Volume

0.2M

Market cap

$42.86M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.35

Dividend yield

—

52W range

$1 – $2

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$17.75

+1590.48%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-1.14M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-7.06M	$-11.98M	$-7.85M	$-10.44M	$-5.98M
EPS	—	—	—	—	$-1.35
Free cash flow	$-5.60M	$-4.53M	$-5.56M	$-4.66M	$-1.14M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
MIRA	$42.86M	18	4.3	3.0	5.0	6.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

MIRA Pharmaceuticals, Inc. Common Stock trades at $1.05. Our Smart Value Score of 18/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is MIRA Pharmaceuticals, Inc. Common Stock's stock price?

MIRA Pharmaceuticals, Inc. Common Stock (MIRA) trades at $1.05.

Is MIRA Pharmaceuticals, Inc. Common Stock overvalued?

Smart Value Score 18/100 (Grade F, Strong Sell).

What is the price target of MIRA Pharmaceuticals, Inc. Common Stock (MIRA)?

The analyst target price is $17.75, representing +1590.5% upside from the current price of $1.05.

Piotroski F-Score?

2/9 — weak financial health.

Company info

SectorHEALTHCARE

IndustryDRUG MANUFACTURERS - GENERAL

CountryUSA

ExchangeNASDAQ

CurrencyUSD

mirapharmaceuticals.com

Quick metrics

P/S ratio—

ROE-165.90%

Beta1.94

50D MA$1.13

200D MA$1.37

Shares out0.04B

Float0.04B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

MIRA vs LLY →MIRA vs JNJ →MIRA vs ABBV →Stock screener →